Joe, nice summary. As I read it the word Trust comes to mind. We all started to loose it with REK, and as it turns out with more good reason than we thought.
As Jim, yourself, and many others have pointed out, that woman couldn't raise money on Bay street, and for good reason, no one trusted her.
She couldn't tell us why Pennsaid was floundering at the FDA, because she knew she couldn't raise the money to do the trials they wanted. She couldn't speed the WF10 data collection along because she couldn't get the money to do the work. Recently, she couldn't tell us that she was spending eight times the returns to sell Pennsaid in Britian. Why, because the good ship Dimethaid couldn't absorb many more blows. And why was that freaky for her? Because she couldn't raise the money to maintain her salary.
Contrast her with new management. They are giving us the facts. Kuhne appears to be onside with them; his interest seems to be less on monetary returns than on the success of Dimethaid. (Gee, what a change of sentiment.) I can already feel that Trust thing starting to build. Maybe, just maybe, they will be able to do a conventional financing on Bay Street. |
